BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8287372)

  • 1. Lipids alter the level and distribution of mouse mammary tumor virus gp52 in vitro.
    Sunzeri FJ; Buehring GC
    Cancer Lett; 1993 Oct; 74(1-2):57-64. PubMed ID: 8287372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative flow cytometry of mouse mammary tumor virus envelope glycoprotein (gp52): alternative measures of hormone-mediated change in a viral cell surface antigen.
    Ritzi EM
    J Virol Methods; 1992 Oct; 40(1):11-30. PubMed ID: 1331158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids stimulate the release of a viral tumor marker (MMTV gp52) while inhibiting tumor cell growth.
    Ritzi EM; Walthall EB
    J Steroid Biochem; 1989 Apr; 32(4):499-505. PubMed ID: 2542692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of mouse mammary tumor virus envelope glycoprotein (Gp52) by growth factors.
    Ritzi EM; Walthall EB
    Intervirology; 1988; 29(3):144-53. PubMed ID: 2846465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shedding of virus-free MMTV gp52 by nonproducer mammary tumor cells: a source of tumor marker in the presence and absence of dexamethasone.
    Ritzi EM; Walthall EB
    Intervirology; 1989; 30(2):102-10. PubMed ID: 2542180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive and negative modification of dexamethasone-mediated MMTV gp52 release by progesterone pretreatment of tumor cells.
    Ritzi EM; Walthall EB
    Intervirology; 1989; 30(2):111-6. PubMed ID: 2542181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
    Ritzi EM; Pyo S
    Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.
    Schochetman G; Arthur LO; Long CW; Massey RJ
    J Virol; 1979 Oct; 32(1):131-9. PubMed ID: 94356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of mouse mammary tumor virus gp52 abundance by protein A assay: a comparison of viral antigen expression on C3H and GR mammary tumor cells.
    Callis AH; Ritzi EM
    Intervirology; 1981; 15(2):111-20. PubMed ID: 6271704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoelectron microscopic localization of mammary tumor virus (MTV) antigens in normal and cancerous mammary glands of mice.
    Tsubura A; Shikata N; Hilgers J; Zotter S; Tanaka H; Morii S
    Microbiol Immunol; 1987; 31(7):665-74. PubMed ID: 2830473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second messengers induced by the envelope protein of a retrovirus.
    Bolander FF
    Mol Cell Endocrinol; 1997 Apr; 129(1):27-32. PubMed ID: 9175626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced production of mouse mammary tumor virus in dexamethasone-treated, 5-iododeoxyuridine-stimulated mammary tumor cell cultures.
    Fine DL; Plowman JK; Kelley SP; Arthur LO; Hillman EA
    J Natl Cancer Inst; 1974 Jun; 52(6):1881-6. PubMed ID: 4134501
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection and characterization of mouse mammary tumor virus cell surface antigens: estimation of antigen abundance by protein A assay.
    Callis AH; Ritzi EM
    J Virol; 1980 Sep; 35(3):876-87. PubMed ID: 6252344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic and antigenic properties of mouse mammary tumor virus produced in a hormone-responsive fashion by C57Bl/10 mammary tumors of non-viral origin.
    Marchetti A; Svec J; Hlavay E; Veselovska Z; Castagna M; Squartini F
    Tumori; 1988 Jun; 74(3):261-7. PubMed ID: 2456634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and disposition of the murine mammary tumor virus (MuMTV) envelope gene products by murine mammary tumor cells.
    Sarkar NH; Racevskis J
    Virology; 1983 Apr; 126(1):279-300. PubMed ID: 6302986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of 2-deoxyglucose and tunicamycin on the biosynthesis of the murine mammary tumor virus proteins, and on the assembly and release of the virus.
    Sarkar NH
    Virology; 1986 Apr; 150(2):419-38. PubMed ID: 3008416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar localization of mouse mammary tumor virus proteins in T-cell lymphomas.
    Hoch-Marchaim H; Hasson T; Rorman E; Cohen S; Hochman J
    Virology; 1998 Mar; 242(2):246-54. PubMed ID: 9514962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the mouse mammary tumor virus (MMTV) binding site in cultured mammary tissue.
    Bolander FF
    Mol Cell Endocrinol; 1991 Dec; 82(2-3):137-42. PubMed ID: 1665450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterization of mouse mammary tumor virus p10 and its presence in mammary tumors and sera of tumor-bearing mice.
    Arthur LO; Fine DL
    J Virol; 1979 Apr; 30(1):148-56. PubMed ID: 90156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.